Roxadustat promotes allograft recovery after kidney transplantation: A prospective, multicenter, randomized controlled trial
Background: Kidney transplantation is the most effective treatment for end-stage kidney disease. However, delayed graft function (DGF) remains a common complication. Roxadustat effectively treats renal anemia and ameliorates acute kidney injury. However, its efficacy in kidney transplant recipients...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Asian Journal of Surgery |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958425003069 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|